Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

2338 ARTÍCULOS , VIENDO DEL 1351 AL 1365

Modafinil for the treatment of antipsychotic-induced excessive daytime sedation: does it exacerbate tics?

Saraf G, Viswanath B, Narayanaswamy JC, Holla B, Math SB.

J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):E35-6. doi: 10.1176/appi.neuropsych.12100246.

Pharmacotherapeutic challenges in the management of attention-deficit/hyperactivity disorder and chronic tics in a school aged child

Sood R, Coffey BJ.

J Child Adolesc Psychopharmacol. 2013 Nov;23(9):628-31. doi: 10.1089/cap.2013.2392.

Functional MRI-navigated repetitive transcranial magnetic stimulation over supplementary motor area in chronic tic disorders

Wu SW, Maloney T, Gilbert DL, Dixon SG, Horn PS, Huddleston DA, Eaton K, Vannest J.

Brain Stimul. 2014 Mar-Apr;7(2):212-8. doi: 10.1016/j.brs.2013.10.005. Epub 2013 Oct 29.

Annual research review: The neurobehavioral development of multiple memory systems--implications for childhood and adolescent psychiatric disorders

Goodman J, Marsh R, Peterson BS, Packard MG.

J Child Psychol Psychiatry. 2014 Jun;55(6):582-610. doi: 10.1111/jcpp.12169. Epub 2013 Nov 29.

Practice parameter for the assessment and treatment of children and adolescents with tic disorders

Murphy TK, Lewin AB, Storch EA, Stock S; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI).

J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1341-59. doi: 10.1016/j.jaac.2013.09.015.

An introduction to the clinical phenomenology of Tourette syndrome

Martino D, Madhusudan N, Zis P, Cavanna AE.

Int Rev Neurobiol. 2013;112:1-33. doi: 10.1016/B978-0-12-411546-0.00001-9.

Functional neuroanatomy of tics

Neuner I, Schneider F, Shah NJ.

Int Rev Neurobiol. 2013;112:35-71. doi: 10.1016/B978-0-12-411546-0.00002-0.

Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome

Udvardi PT, Nespoli E, Rizzo F, Hengerer B, Ludolph AG.

Int Rev Neurobiol. 2013;112:95-130. doi: 10.1016/B978-0-12-411546-0.00004-4.

Reinforcement learning and Tourette syndrome

Palminteri S, Pessiglione M.

Int Rev Neurobiol. 2013;112:131-53. doi: 10.1016/B978-0-12-411546-0.00005-6.

Genetic susceptibility and neurotransmitters in Tourette syndrome

Paschou P, Fernandez TV, Sharp F, Heiman GA, Hoekstra PJ.

Int Rev Neurobiol. 2013;112:155-77. doi: 10.1016/B978-0-12-411546-0.00006-8.

Pharmacological animal models of tic disorders

McCairn KW, Isoda M.

Int Rev Neurobiol. 2013;112:179-209. doi: 10.1016/B978-0-12-411546-0.00007-X.

Animal models recapitulating the multifactorial origin of Tourette syndrome

Macrì S, Onori MP, Roessner V, Laviola G.

Int Rev Neurobiol. 2013;112:211-37. doi: 10.1016/B978-0-12-411546-0.00008-1.

Neuroendocrine aspects of Tourette syndrome

Martino D, Macerollo A, Leckman JF.

Int Rev Neurobiol. 2013;112:239-79. doi: 10.1016/B978-0-12-411546-0.00009-3.

Clinical pharmacology of dopamine-modulating agents in Tourette's syndrome

Mogwitz S, Buse J, Ehrlich S, Roessner V.

Int Rev Neurobiol. 2013;112:281-349. doi: 10.1016/B978-0-12-411546-0.00010-X.

Clinical pharmacology of nondopaminergic drugs in Tourette syndrome

Hartmann A.

Int Rev Neurobiol. 2013;112:351-72. doi: 10.1016/B978-0-12-411546-0.00011-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias